Found 44 matching trials
A Study of Participants With Advanced Prostate Cancer in Canada
N/AThe purpose of this study is to document the course of advanced prostate ca...
Location
Tom Baker Cancer Center
Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
PHASE2The goal of this clinical trial is to study definitive external beam radiat...
Location
University of California San Diego
PET/CT Characterization of Treatment Resistance
NAThis study will use different types of medical imaging to assess how lesion...
Location
University of Wisconsin
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
PHASE3The aim is to investigate whether the addition of short-term androgen depri...
Location
University Hospitals Leuven
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
PHASE3This is a Phase III, international, multicentre, randomised, double-blinded...
Location
Grand Hopital de Charleroi - site Notre Dame
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent
PHASE3To demonstrate the efficacy of VERU-111 (Sabizabulin) in the treatment of m...
Location
Alaska Oncology and Hematology, LLC.
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
PHASE2The proposed clinical trial will study the effects of 12 months of therapy ...
Location
Multiple Locations
An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC
PHASE3This study is a prospective, open-label, phase III, randomized controlled c...
Location
Multiple Locations
COMbination of Bipolar Androgen Therapy and Nivolumab
PHASE2Single arm, multicenter, open-label Phase II study of the effects of parent...
Location
UCSF Helen Diller Family Comprehensive Cancer Center
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
PHASE2PRO-BOOST-N is a prospective, multicenter, randomized phase II/III clinical...
Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy